Ownership history in HARDING LOEVNER LP · 37 quarters on record
This page tracks every 13F SEC filing in which HARDING LOEVNER LP reported a position in GENMAB A/S (GMAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 3,370,143 | -114,344 | -3.3% | 0.91% | $103.9M | $30.80 |
| 2025 Q3 | ADDED | 3,484,487 | +561,048 | +19.2% | 0.78% | $106.9M | $30.67 |
| 2025 Q2 | ADDED | 2,923,439 | +42,613 | +1.5% | 0.41% | $60.4M | $20.66 |
| 2025 Q1 | ADDED | 2,880,826 | +637,434 | +28.4% | 0.43% | $56.4M | $19.58 |
| 2024 Q4 | REDUCED | 2,243,392 | -823,550 | -26.9% | 0.32% | $46.8M | $20.87 |
| 2024 Q3 | ADDED | 3,066,942 | +299,137 | +10.8% | 0.43% | $74.7M | $24.38 |
| 2024 Q2 | REDUCED | 2,767,805 | -526,923 | -16.0% | 0.38% | $69.6M | $25.13 |
| 2024 Q1 | ADDED | 3,294,728 | +4,833 | +0.1% | 0.61% | $98.5M | $29.91 |
| 2023 Q4 | ADDED | 3,289,895 | +85,665 | +2.7% | 0.55% | $97.6M | $31.84 |
| 2023 Q3 | ADDED | 3,204,230 | +3,036,109 | +1805.9% | 0.75% | $113.0M | $35.27 |
As of 2025 Q4 — sorted by position size